1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT04098081 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04098081
- Sponsor
- University of Maryland, Baltimore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2026-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.